Takeda Pharmaceutical (TAK) Operating Margin Growth (5y) (2022 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Operating Margin Growth (5y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn |
| 2 | AbbVie | 443.13 Bn | 436.56 Bn | 12.70 Bn |
| 3 | Merck | 365.40 Bn | 358.26 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.79 Bn | 259.10 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.92 Bn | 43.92 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.18 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -966.00 |
| Mar 31, 2026 | -1,576.00 |
| Dec 31, 2025 | -5,513.00 |
| Sep 30, 2025 | 585.00 |
| Jun 30, 2025 | -419.00 |
| Mar 31, 2025 | -1,805.00 |
| Sep 30, 2024 | 396.00 |
| Jun 30, 2024 | 845.00 |
| Mar 31, 2024 | -1,201.00 |
| Dec 31, 2023 | -1,409.00 |
| Sep 30, 2023 | -446.00 |
| Jun 30, 2023 | -606.00 |
| Mar 31, 2023 | 3,600.00 |
| Dec 31, 2022 | -461.00 |